Abstract:Background and AimHigh autoimmune hepatitis (AIH) and overlap syndrome (OS) prevalence have been previously documented among Alaska Native people. The purpose of this project is to report changes in AIH/OS prevalence over time, clinical characteristics, and factors associated with biochemical remission.MethodsWe reviewed medical records for Alaska Native/American Indian (AN/AI) patients diagnosed with AIH/OS between 1984 and 2021. Point prevalence was calculated based on AIH/OS patients alive at the end of 202… Show more
“…Regarding AIH, the prevalence of 12.3 per 100,000 is lower than reported for most North European countries, including Denmark with a prevalence of 23.9 per 100,000 [ 12 , 24 ]. Notably, AIH is also less prevalent in Greenland than among Inuit in Alaska, who are included in the “Alaska Natives” minority population with a record-high AIH prevalence of 91.2 per 100,000 [ 11 ]. Hence, although Inuit in Greenland and Alaska share unique genetics, this seems to have little influence on the susceptibility to develop AIH.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, the burden of autoimmune diseases may also resemble that of Western countries, as recently reported for autoimmune inflammatory bowel diseases [ 9 ]. Hepatologists practicing in Circumpolar areas refer to studies investigating AIH, PBC, PSC, and AIH with overlap disease in Alaska natives [ 10 , 11 ]. These studies reported a high and rising prevalence of AIH and AIH with overlap disease and a similar prevalence of PBC compared to Scandinavian countries, while no patients with PSC were identified [ 10–14 ].…”
Autoimmune liver diseases are rare serious diseases causing chronic inflammation and fibrosis in the liver parenchyma and bile ducts. Yet, the prevalence and burden of autoimmune liver diseases are largely unexplored in Arctic native populations. We investigated the prevalence and management of autoimmune liver diseases in Greenland using nationwide cross-sectional register data and subsequent medical chart reviews validating diagnoses and extracting liver histology examinations and medical treatments. The overall prevalence of autoimmune liver diseases in Greenland was 24.6 per 100,000 (95% CI: 14.7–41.3). This was based on 7 patients with autoimmune hepatitis (AIH) (12.3 per 100,000), 3 patients with primary biliary cholangitis (PBC) (5.3 per 100,000), 4 patients with AIH/PBC overlap disease (7.0 per 100,000), and no patients with primary sclerosing cholangitis. All diagnoses were confirmed by liver histology examinations. Medical treatments adhered to internal recommendations and induced complete remission in most patients with AIH, and complete or partial remission in 1 patient with PBC and 3 patients with AIH/PBC overlap disease. One patient had established cirrhosis at the time of diagnosis, while 2 patients progressed to cirrhosis. In conclusion, the prevalence of autoimmune liver diseases was lower in Greenland than in Scandinavia and among Alaska Inuit.
“…Regarding AIH, the prevalence of 12.3 per 100,000 is lower than reported for most North European countries, including Denmark with a prevalence of 23.9 per 100,000 [ 12 , 24 ]. Notably, AIH is also less prevalent in Greenland than among Inuit in Alaska, who are included in the “Alaska Natives” minority population with a record-high AIH prevalence of 91.2 per 100,000 [ 11 ]. Hence, although Inuit in Greenland and Alaska share unique genetics, this seems to have little influence on the susceptibility to develop AIH.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, the burden of autoimmune diseases may also resemble that of Western countries, as recently reported for autoimmune inflammatory bowel diseases [ 9 ]. Hepatologists practicing in Circumpolar areas refer to studies investigating AIH, PBC, PSC, and AIH with overlap disease in Alaska natives [ 10 , 11 ]. These studies reported a high and rising prevalence of AIH and AIH with overlap disease and a similar prevalence of PBC compared to Scandinavian countries, while no patients with PSC were identified [ 10–14 ].…”
Autoimmune liver diseases are rare serious diseases causing chronic inflammation and fibrosis in the liver parenchyma and bile ducts. Yet, the prevalence and burden of autoimmune liver diseases are largely unexplored in Arctic native populations. We investigated the prevalence and management of autoimmune liver diseases in Greenland using nationwide cross-sectional register data and subsequent medical chart reviews validating diagnoses and extracting liver histology examinations and medical treatments. The overall prevalence of autoimmune liver diseases in Greenland was 24.6 per 100,000 (95% CI: 14.7–41.3). This was based on 7 patients with autoimmune hepatitis (AIH) (12.3 per 100,000), 3 patients with primary biliary cholangitis (PBC) (5.3 per 100,000), 4 patients with AIH/PBC overlap disease (7.0 per 100,000), and no patients with primary sclerosing cholangitis. All diagnoses were confirmed by liver histology examinations. Medical treatments adhered to internal recommendations and induced complete remission in most patients with AIH, and complete or partial remission in 1 patient with PBC and 3 patients with AIH/PBC overlap disease. One patient had established cirrhosis at the time of diagnosis, while 2 patients progressed to cirrhosis. In conclusion, the prevalence of autoimmune liver diseases was lower in Greenland than in Scandinavia and among Alaska Inuit.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.